ImageneBio, Inc.
IMA- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001835579
In the last 90 days, ImageneBio, Inc. insiders filed 0 open-market purchases and 1 sale; 35 institutions reported holding it in 13F filings for Q2 2026, worth $36.8M in total; no superinvestor holds it.
13F holders, Q4 2025
Institutional positions in ImageneBio, Inc. as of Dec 31, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 41
- +8 vs. Q3 2025
- Shares held
- 4.77M
- +21.0K (+0.4%) vs. Q3 2025
- Total value
- $32.9M
- −$5.43M (−14.2%) vs. Q3 2025
- New holders
- 14
- 12 more added
- Sold out
- 6
- 5 more reduced
Compare with Q3 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting IMA on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 35 | $36.8M |
| Q1 2026 | 39 | $26.8M |
| Q4 2025 | 41 | $32.9M |
| Q3 2025 | 33 | $38.3M |
| Q2 2025 | 41 | $42.6M |
| Q1 2025 | 46 | $41.9M |
| Q4 2024 | 53 | $52.0M |
| Q3 2024 | 57 | $49.1M |
| Q2 2024 | 70 | $47.9M |
| Q1 2024 | 57 | $42.7M |
| Q4 2023 | 54 | $63.8M |
| Q3 2023 | 58 | $141.6M |
| Q2 2023 | 52 | $204.7M |
| Q1 2023 | 39 | $86.2M |
| Q4 2022 | 34 | $69.9M |
| Q3 2022 | 42 | $93.2M |
| Q2 2022 | 46 | $118.7M |
| Q1 2022 | 48 | $167.8M |
| Q4 2021 | 49 | $343.6M |
| Q3 2021 | 39 | $271.8M |
| Q2 2021 | 42 | $293.2M |
| Q1 2021 | 27 | $538.5M |
Institutions, Q4 2025
Shares, value and share of portfolio for each institution holding ImageneBio, Inc.; share changes are against Q3 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Avion Wealth | 57 | $0 | 0.00% | +57 | New |
| BNP Paribas Arbitrage, SA | 24 | $166 | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 41 | $283 | 0.00% | 00.0% | Unchanged |
| JPMorgan Chase & Co | 70 | $483 | 0.00% | 00.0% | Unchanged |
| Fortitude Family Office, LLC | 400 | $2.76K | 0.00% | +400 | New |
| GWM Advisors LLC | 491 | $3.39K | 0.00% | −12,469−96.2% | Reduced |
| Royal Bank of Canada | 1,000 | $7.00K | 0.00% | +1,000 | New |
| Bank of America Corp | 2,597 | $17.9K | 0.00% | +2,571+9,888.5% | Added |
| UBS Group AG | 4,961 | $34.2K | 0.00% | +191+4.0% | Added |
| Morgan Stanley | 10,771 | $74.3K | 0.00% | +9,485+737.6% | Added |
| Barclays PLC | 10,797 | $74.5K | 0.00% | +6,810+170.8% | Added |
| Goldman Sachs Group Inc | 10,950 | $75.6K | 0.00% | +10,950 | New |
| Millennium Management LLC | 11,454 | $79.0K | 0.00% | +11,454 | New |
| XTX Topco Ltd | 12,177 | $84.0K | 0.00% | −32,774−72.9% | Reduced |
| T3 Companies, LLC | 13,200 | $91.1K | 0.12% | +13,200 | New |
| Prelude Capital Management, LLC | 13,495 | $93.1K | 0.01% | +13,495 | New |
| Jane Street Group, LLC | 14,896 | $102.8K | 0.00% | +14,896 | New |
| Rangeley Capital, LLC | 18,244 | $125.9K | 0.11% | +3,244+21.6% | Added |
| Jacobs Levy Equity Management, Inc | 18,727 | $129.2K | 0.00% | +1,019+5.8% | Added |
| Aldebaran Capital, LLC | 19,070 | $131.6K | 0.12% | −492−2.5% | Reduced |
| Shay Capital LLC | 23,216 | $160.2K | 0.03% | +23,216 | New |
| Nano Cap New Millennium Growth Fund L P | 26,500 | $182.8K | 0.16% | +26,500 | New |
| Sofinnova Investments, Inc. | 31,884 | $220.0K | 0.01% | 00.0% | Unchanged |
| HSBC Holdings PLC | 34,228 | $233.1K | 0.00% | +34,228 | New |
| DRW Securities, LLC | 43,768 | $302.0K | 0.02% | +43,768 | New |
| Squarepoint Ops LLC | 48,237 | $332.8K | 0.00% | +24,067+99.6% | Added |
| NEA Management Company, LLC | 50,005 | $345.0K | 0.02% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 54,146 | $373.6K | 0.00% | +6,458+13.5% | Added |
| Renaissance Technologies LLC | 66,096 | $456.1K | 0.00% | +28,718+76.8% | Added |
| Adage Capital Partners GP, L.L.C. | 66,666 | $460.0K | 0.00% | 00.0% | Unchanged |
| Citadel Advisors LLC | 86,478 | $596.7K | 0.00% | −35,769−29.3% | Reduced |
| Monashee Investment Management LLC | 91,621 | $632.2K | 0.36% | +91,621 | New |
| BlackRock, Inc. | 131,587 | $908.0K | 0.00% | +79,476+152.5% | Added |
| BML Capital Management, LLC | 177,026 | $1.22M | 1.08% | −5,483−3.0% | Reduced |
| Vanguard Group Inc | 238,000 | $1.64M | 0.00% | +4,642+2.0% | Added |
| RTW Investments, LP | 334,445 | $2.31M | 0.02% | 00.0% | Unchanged |
| OrbiMed Advisors LLC | 378,556 | $2.61M | 0.05% | 00.0% | Unchanged |
| Omega Fund Management, LLC | 455,361 | $3.14M | 1.10% | 00.0% | Unchanged |
| Cable Car Capital LLC | 643,933 | $4.44M | 0.28% | +643,933 | New |
| BVF Inc | 802,102 | $5.53M | 0.19% | 00.0% | Unchanged |
| Blue Owl Capital Holdings LP | 823,785 | $5.68M | 1.75% | +282,861+52.3% | Added |
| Deep Track Capital, LP | 0 | $0 | 0.00% | −878,516−100.0% | Sold out |
| Atlas Venture Life Science Advisors, LLC | 0 | $0 | 0.00% | −377,814−100.0% | Sold out |
| Bridgeway Capital Management, LLC | 0 | $0 | 0.00% | −12,774−100.0% | Sold out |
| Tower Research Capital LLC (TRC) | 0 | $0 | 0.00% | −877−100.0% | Sold out |
| Federated Hermes, Inc. | 0 | $0 | 0.00% | −204−100.0% | Sold out |
| FMR LLC | 0 | $0 | 0.00% | −67−100.0% | Sold out |